Summit Therapeutics (SMMT) Q3 2024 Earnings

6AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.06
-0.05
-0.04
-0.03

Details

Expected EPS
-0.061862
Actual EPS
-0.05
Surprise EPS
0.01
Surprise Percent
+19.17%

Description

Summit Therapeutics (SMMT) has reported earnings of -0.05 per share for Q3 2024.

0 Comments

Share your thoughts